Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy

Retina. Jul-Aug 2006;26(6):699-700. doi: 10.1097/01.iae.0000225351.87205.69.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Combined Modality Therapy
  • Diabetes Mellitus, Type 1 / complications
  • Diabetic Retinopathy / complications*
  • Epiretinal Membrane / surgery
  • Humans
  • Injections
  • Laser Coagulation
  • Male
  • Retinal Detachment / drug therapy*
  • Retinal Detachment / surgery*
  • Sulfur Hexafluoride / administration & dosage
  • Vitrectomy*
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Sulfur Hexafluoride